Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The DFINE STAR™ Tumor Ablation Prospective Clinical Series

NCT02217150 is registered in ClinicalTrials.gov with DFINE Inc. as lead sponsor.

NCT NCT02217150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02217150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The DFINE STAR™ Tumor Ablation Prospective Clinical Series
Lead sponsor
DFINE Inc.
Phase
Observational
Overall status
Completed
Start date
June 30, 2013
Completion date
April 30, 2016
Enrollment
50 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

metastasis to vertebral column